| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP Clinical Reg Affairs | VP Clinical Reg. Affairs
1 company
Thompson Jaye is a VP Clinical Reg Affairs at Greenwich LifeSciences, Inc.. Recent SEC Form 4 filings include 10 buys and 0 sells.
Estimated insider holdings value: $6.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 24, 2023 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 250 | $15.40 | $3,848.75 | - | |
| Feb 3, 2023 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 250 | $20.84 | $5,210.00 | - | |
| Jan 27, 2023 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 250 | $19.20 | $4,800.00 | - | |
| Jan 13, 2023 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 250 | $16.50 | $4,125.00 | - | |
| Dec 16, 2022 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 250 | $12.94 | $3,235.00 | - | |
| Dec 2, 2022 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 250 | $13.98 | $3,495.00 | - | |
| Apr 19, 2022 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 500 | $16.74 | $8,370.00 | +0.2% | |
| Jan 31, 2022 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 500 | $18.47 | $9,235.00 | +0.2% | |
| Jan 21, 2022 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 500 | $16.33 | $8,165.00 | +0.2% | |
| Jan 18, 2022 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg. Affairs | Buy | 500 | $18.87 | $9,435.00 | +0.2% |